EUR 4.45
(0.23%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 17.6 Million EUR | -27.84% |
2022 | 24.4 Million EUR | -18.08% |
2021 | 29.78 Million EUR | -14.27% |
2020 | 34.74 Million EUR | 20.45% |
2019 | 28.84 Million EUR | -8.91% |
2018 | 31.67 Million EUR | 11.66% |
2017 | 28.36 Million EUR | 9.38% |
2016 | 25.93 Million EUR | -0.92% |
2015 | 26.17 Million EUR | -3.17% |
2014 | 27.03 Million EUR | 4.48% |
2013 | 25.87 Million EUR | 4.37% |
2012 | 24.78 Million EUR | 2.86% |
2011 | 24.1 Million EUR | 0.88% |
2010 | 23.88 Million EUR | -8.17% |
2009 | 26.01 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 174 Thousand EUR | 0.0% |
2023 Q4 | 2.65 Million EUR | 0.0% |
2023 Q3 | 2.65 Million EUR | -61.76% |
2023 Q2 | 6.94 Million EUR | 13.05% |
2023 Q1 | 6.14 Million EUR | 106.34% |
2023 FY | 17.6 Million EUR | -27.84% |
2022 FY | 24.4 Million EUR | -18.08% |
2022 Q1 | 7.67 Million EUR | 647.23% |
2022 Q2 | 10.01 Million EUR | 30.54% |
2022 Q3 | 4.5 Million EUR | -55.01% |
2022 Q4 | 2.97 Million EUR | -33.91% |
2021 FY | 29.78 Million EUR | -14.27% |
2021 Q1 | 8.21 Million EUR | -12.21% |
2021 Q2 | 6.17 Million EUR | -24.77% |
2021 Q3 | 7.1 Million EUR | 14.93% |
2021 Q4 | 1.02 Million EUR | -85.54% |
2020 FY | 34.74 Million EUR | 20.45% |
2020 Q1 | 7.6 Million EUR | 37.72% |
2020 Q2 | 5.21 Million EUR | -31.4% |
2020 Q3 | 10.04 Million EUR | 92.56% |
2020 Q4 | 9.35 Million EUR | -6.86% |
2019 Q3 | 7.21 Million EUR | 93.21% |
2019 Q4 | 5.52 Million EUR | -23.52% |
2019 Q1 | 6.68 Million EUR | 0.0% |
2019 FY | 28.84 Million EUR | -8.91% |
2019 Q2 | 3.73 Million EUR | -44.12% |
2018 FY | 31.67 Million EUR | 11.66% |
2017 Q2 | 7.26 Million EUR | 0.0% |
2017 FY | 28.36 Million EUR | 9.38% |
2017 Q4 | 7.16 Million EUR | 0.0% |
2017 Q3 | 7.16 Million EUR | -1.33% |
2017 Q1 | 7.26 Million EUR | 5.68% |
2016 Q2 | 6.73 Million EUR | 0.0% |
2016 FY | 25.93 Million EUR | -0.92% |
2016 Q4 | 6.87 Million EUR | 0.0% |
2016 Q1 | 6.73 Million EUR | 8.52% |
2016 Q3 | 6.87 Million EUR | 2.12% |
2015 Q4 | 6.2 Million EUR | 0.0% |
2015 Q3 | 6.2 Million EUR | 1.11% |
2015 Q2 | 6.13 Million EUR | 0.0% |
2015 FY | 26.17 Million EUR | -3.17% |
2015 Q1 | 6.13 Million EUR | -10.12% |
2014 Q1 | 6.2 Million EUR | -6.01% |
2014 Q4 | 6.82 Million EUR | 0.0% |
2014 Q3 | 6.82 Million EUR | 10.01% |
2014 FY | 27.03 Million EUR | 4.48% |
2014 Q2 | 6.2 Million EUR | 0.0% |
2013 Q1 | 6.68 Million EUR | 3.03% |
2013 Q3 | 6.6 Million EUR | -1.24% |
2013 Q4 | 6.6 Million EUR | 0.0% |
2013 FY | 25.87 Million EUR | 4.37% |
2013 Q2 | 6.68 Million EUR | 0.0% |
2012 Q4 | 6.48 Million EUR | 0.0% |
2012 Q2 | 6.48 Million EUR | 0.0% |
2012 FY | 24.78 Million EUR | 2.86% |
2012 Q1 | 6.48 Million EUR | 3.53% |
2012 Q3 | 6.48 Million EUR | 0.08% |
2011 Q4 | 6.26 Million EUR | 0.0% |
2011 Q3 | 6.26 Million EUR | 0.0% |
2011 FY | 24.1 Million EUR | 0.88% |
2010 FY | 23.88 Million EUR | -8.17% |
2009 FY | 26.01 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | -48.401% |
Bluelinea Société Anonyme | 11.43 Thousand EUR | -153840.248% |
Carmat SA | 21.54 Million EUR | 18.279% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | 2.754% |
Eurobio Scientific Société anonyme | 47.34 Million EUR | 62.808% |
Ikonisys S.A. | 2.44 Million EUR | -618.874% |
Implanet S.A. | 9.29 Million EUR | -89.53% |
Median Technologies SA | 46.34 Million EUR | 62.002% |
SpineGuard SA | 7.35 Million EUR | -139.414% |
Theraclion SA | -1.08 Million EUR | 1729.903% |
Euroapi S.A. | 398.9 Million EUR | 95.586% |
Guerbet SA | 550.79 Million EUR | 96.803% |
Ion Beam Applications SA | 128.02 Million EUR | 86.245% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 99.699% |
Sequana Medical NV | 30.03 Million EUR | 41.38% |